Semaglutide, a synthetic analog of glucagon-like peptide-1 (GLP-1), has garnered attention for its intriguing properties and potential implications in various r ...

Weight-loss drugs like Ozempic and Wegovy are used by more than 15 million adults in the U.S., or 4.5% of the population.

Ascendis Pharma has reported week 26 interim analysis outcomes from the Phase II COACH Trial assessing TransCon CNP and ...

Count podcast host Joe Rogan, 57, among the fans of BPC-157 — he reported that it cleared up his elbow tendonitis in just two ...

Amplifye, a startup led by former Amyris CEO John Melo, has launched its first product: an enzyme claimed to optimize protein ...

The combination of TransCon hGH and TransCon CNP demonstrated accelerated improvement in body proportionality at Week 26, ...

Long used in topical skin-care products for their ability to promote collagen production, peptides have become the panacea ...

Reviewing the bioequivalence study of the antidiabetic drug Semaglutide of MSN Laboratories, the Subject Expert Committee ...

Drug major Cipla has received approval from the Subject Expert Committee (SEC) functional under the Central Drug Standard ...

CLARE Butler struggled with her weight for most of her adult life. As an emotional eater, food was her go-to whenever she ...

Individualized ocular characteristics should be considered before starting GLP-1 RA therapies for weight loss and diabetes management.

BACKGROUND: Recent studies have highlighted the deleterious role of high phosphate intake in hypertension by means of ...